Study of the mechanism of inhibitory action of tranilast on chemical mediator release.
スポンサーリンク
概要
- 論文の詳細を見る
We investigated the mechanism of inhibitory action of tranilast on chemical mediator release by antigen-antibody reactions. Tranilast (10<SUP>-5</SUP>-10<SUP>-3</SUP> M) inhibited antigen (DNP-Ascaris)-induced histamine release from sensitized purified rat mast cells (PMC), but did not show an obvious influence on intracellular cyclic AMP. <SUP>45</SUP>Ca uptake into PMC induced by antigen (300 μg/ml) was obviously suppressed by tranilast (10<SUP>-6</SUP>-10<SUP>-3</SUP> M). Tranilast (10<SUP>-4</SUP> M) inhibited antigeninduced histamine release from and <SUP>45</SUP>Ca uptake into PMC independently of the presence or absence of glucose in the medium. On the other hand, 2-deoxyglucose (10<SUP>-2</SUP> M) markedly inhibited both responses in the absence but not in the presence of glucose. Tranilast slightly inhibited Ca-induced contraction of guinea pig taenia coli, but had no influence on aggregation of rabbit platelets. Verapamil (10<SUP>-6</SUP>-10<SUP>-4</SUP> M) had no effect on antigen-induced histamine release, but it markedly suppressed Ca-induced contraction and platelet aggregation. From these results, we suggest that the mechanism of inhibitory action of tranilast on the release of antigen-induced chemical mediator from mast cells involves the suppression of Ca uptake, but that its mode of action is apparently different from those of 2-deoxyglucose and verapamil.
著者
-
Kojima Masami
Central Research Laboratory Kissei Pharmaceutical
-
Kusama Hiroshi
Central Research Laboratories Kissei Pharmaceutical Co. Ltd.
-
UJIIE Arao
Central Research Laboratories, Kissei Pharmaceutical Co., Ltd.
-
Ujiie Arao
Central Research Laboratories Kissei Pharmaceutical Co. Ltd.
-
NAKAZAWA MASAYUKI
Central Research Laboratories, Kissei Pharmaceutical Co., Ltd.
-
Tsutsumi Naoyuki
Central Research Laboratories Kissei Pharmaceutical Co. Ltd.
-
Hamano Shuichiro
Central Research Laboratories Kissei Pharmaceutical Co. Ltd.
-
Kusama Hiroshi
Central Research Laboratories, Kissei Pharmaceutical Co., Ltd.
-
KOMATSU Hidetada
Central Research Laboratories, Kissei Pharmaceutical Co., Ltd.
-
IKEDA Shigeru
Central Research Laboratories, Kissei Pharmaceutical Cc., Ltd.
-
KOMATSU Hidetada
Central Research Laboratories, Kissei Pharmaceutical Cc., Ltd.
関連論文
- Antimetastatic Activities of Synthetic Arg-Gly-Asp-Ser (RGDS) and Arg-Leu-Asp-Ser (RLDS) Peptide Analogues and Their Inhibitory Mechanisms
- Synthetic Arg-Gly-Asp-Ser Analogues of the Cell Recognition Site of Fibronectin That Retain Antimetastatic and Anti-cell Adhesive Properties
- Discovery of Novel 2-Anilinopyrazolo[1,5-a]pyrimidine Derivatives as c-Src Kinase Inhibitors for the Treatment of Acute Ischemic Stroke
- A Rapid- and Short-Acting Hypoglycemic Agent KAD-1229 Improves Post-Prandial Hyperglycemia and Diabetic Complications in Streptozotocin-Induced Non-Insulin-Dependent Diabetes Mellitus Rats
- Low-Molecular-Weight Heparin (Dalteparin) Demonstrated a Weaker Effect on Rat Bone Metabolism Compared with Heparin
- Treatment effects of bisphosphonates on ovariectomy-induced osteopenia in rats: Comparison between clodronate and etidronate
- Effect of Cabergoline, a Long-Acting dopamine D_2 Agonist, on Reserpine-Treated Rodents
- Dopamine Receptor Affinities in Vitro and Stereotypic Activities in Vivo of Cabergoline in Rats
- Investigation of Water Mobility and Diffusivity in Hydrating Micronized Low-substituted Hydroxypropyl Cellulose, Hydroxypropylmethyl Cellulose, and Hydroxypropyl Cellulose Matrix Tablets by Magnetic Resonance Imaging (MRI)
- CANINE CORONARY REPERFUSION MODEL AND THE INFLUENCE OF OKY-046, A SPECIFIC TXA_2 SYNTHETASE INHIBITOR : Ischemic Heart Disease (II), Coronary Circulation : II : 48 Annual Scientific Meeting, Japanese Circulation Society
- Pharmacological Profile of KUL-7211, a Selective β-Adrenoceptor Agonist, in Isolated Ureteral Smooth Muscle
- Effects of KCA-012 on Bone Metabolism in Organ Culture
- Studies on New Platelet Aggregation Inhibitors 1. Synthesis of 7-Nitro-3, 4-dihydroquinoline-2(1H)-one Derivatives
- THE SUSCEPTIBILITY OF EXPERIMENTAL GLOMERULONEPHRITIS IN SIX DIFFERENT STRAINS OF MICE
- Mechanism f inhibitory action of tranilast on the release of slow reacting substance of anaphylaxis (SRS-A) in vitro: Effect of tranilast on the release of arachidonic acid and its metabolites.
- Study of the mechanism of inhibitory action of tranilast on chemical mediator release.
- Enzymatic study to characterize the slow reacting substance of anaphylaxis (SRS-A) and leukotrienes.
- Beneficial effect of OKY-046, a selective thromboxane A2 synthetase inhibitor, on experimental cerebral vasospasm.
- Effects of KCA-098 on Bone Metabolism: Comparison with Those of Ipriflavone.
- Inhibitory action of OKY-046HCl, a specific TXA2 synthetase inhibitor, on platelet activating factor(PAF)-induced airway hyperresponsiveness of guinea pigs: Role of TXA2 in development of PAF-induced nonspecific airway hyperresponsiveness.
- Inhibitory effects of OKY-046 on spasmogen-induced bronchoconstrictions in sensitized and non-sensitized guinea pigs.
- Effects of ritodrine hydrochloride, a beta2-adrenoceptor stimulant, on uterine motilities in late pregnancy.
- Pharmacological studies on the TXA2 synthetase inhibitor (E)-3-(p-(1H-imidazol-1-ylmethyl)phenyl)-2-propenoic acid (OKY-046).